GPs could be influenced by pharma, King's Fund warns

By Sarah Calkin2011-08-09T11:55:00

Source: Evgeny Rannev

GP prescribing could become commercially biased if clinical commissioning groups buy in support from drug companies, a report commissioned by the King’s Fund has warned.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here